Charles A. McCaslin, Daniela N. Petrusca, Christophe Poirier, Karina A

Slides:



Advertisements
Similar presentations
Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs  Huey-Ming Lo, Min-Wen Wu, Shiow-Lin.
Advertisements

Sevoflurane pre-conditioning increases phosphorylation of Erk1/2 and HO-1 expression via inhibition of mPTP in primary rat cortical neurons exposed to.
Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin  E.J. Growcott, A. Coulthard,
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice  Ximena.
Christopher C. Miller, Christopher A
Monocyte chemoattractant chemokines in cystic fibrosis
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis  P. McNally, C. Coughlan,
Jane L. Burns, Jean-Marc Rolain  Journal of Cystic Fibrosis 
Neil E. Alexis, Marianne S. Muhlebach, David B. Peden, Terry L. Noah 
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel  Emanuela Pesce, Giulia Gorrieri,
Volume 6, Issue 2, Pages (January 2014)
Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa  Magnus Paulsson,
Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function  Fredrick Van Goor, Haihui Yu, Bill.
Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response  P. Lohan, O. Treacy, K.
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Serum amyloid A is an innate immune opsonin for Gram-negative bacteria
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice  Bob Lubamba, François Huaux, Jean Lebacq, Etienne Marbaix,
Anti-inflammatory effect of miglustat in bronchial epithelial cells
Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25- dihydroxyvitamin D3  Sunghan Yim, Puneet Dhawan, Chandran Ragunath, Sylvia.
Heleen Van Acker, Elisabeth Van Snick, Hans J. Nelis, Tom Coenye 
Enhancement of Pulmozyme activity in purulent sputum by combination with poly- aspartic acid or gelsolin  Robert Bucki, Katrina Cruz, Katarzyna Pogoda,
Inhibitory effects of hypertonic saline on P. aeruginosa motility
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
De Novo Ceramide Synthesis Participates in the Ultraviolet B Irradiation-Induced Apoptosis in Undifferentiated Cultured Human Keratinocytes  Yoshikazu.
Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease  Malin Carlsson, Swati.
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Assessment of strategies to increase chondrocyte viability in cryopreserved human osteochondral allografts: evaluation of the glycosylated hydroquinone,
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Curcumin and genistein additively potentiate G551D-CFTR
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking  Graeme W. Carlile, Renaud Robert, Julie Goepp, Elizabeth Matthes,
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Bronchial epithelial cell lines and primary nasal epithelial cells from cystic fibrosis respond differently to cigarette smoke exposure  Mark Thomas Shaw.
Gemifloxacin inhibits cytokine secretion by lipopolysaccharide stimulated human monocytes at the post-transcriptional level  F. Araujo, T. Slifer, S.
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis  Catriona Kelly, Mark T. Williams, J. Stuart.
Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S
Masato Mizuashi, Tomoyuki Ohtani, Satoshi Nakagawa, Setsuya Aiba 
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Implementation of European standards of care for cystic fibrosis ��� Control and treatment of infection  J.S. Elborn, M. Hodson, C. Bertram  Journal of.
P. aeruginosa drives CXCL8 synthesis via redundant toll-like receptors and NADPH oxidase in CFTR∆F508 airway epithelial cells  Lucie Roussel, Guy Martel,
Combination potentiator (‘co-potentiator’) therapy for CF caused by CFTR mutants, including N1303K, that are poorly responsive to single potentiators 
A.H. Gifford  Journal of Cystic Fibrosis 
17β-Estradiol Enhances the Production of Nerve Growth Factor in THP-1-Derived Macrophages or Peripheral Blood Monocyte-Derived Macrophages  Naoko Kanda,
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Inhalation solutions — Which ones may be mixed
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model  E. Lelong, A. Marchetti, M. Simon,
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled.
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis  Joseph M. Collaco, Karen S. Raraigh, Lawrence.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Characterization of the Sensitizing Potential of Chemicals by In Vitro Analysis of Dendritic Cell Activation and Skin Penetration  Pierre Aeby, Christoph.
Modification of the salivary secretion assay in F508del mice — The murine equivalent of the human sweat test  Karoline Droebner, Peter Sandner  Journal.
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Dysregulated interleukin-8 secretion and NF-κB activity in human cystic fibrosis nasal epithelial cells  Salvatore Carrabino, Daniela Carpani, Alessandra.
Volume 15, Issue 11, Pages (June 2016)
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
CFTR modulators and pregnancy: Our work has only just begun
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling  B. Müller-Edenborn, R. Frick, T. Piegeler,
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance  Charles A. McCaslin, Daniela N. Petrusca, Christophe Poirier, Karina A. Serban, Gregory G. Anderson, Irina Petrache  Journal of Cystic Fibrosis  Volume 14, Issue 1, Pages 70-77 (January 2015) DOI: 10.1016/j.jcf.2014.06.009 Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Effect of sodium alginate on efferocytosis. (A) Schematic of efferocytosis flow-cytometry method. Macrophage population was gated on FSC/SSC (gate B) and set for negative fluorescence (autofluorescence) on FSC/FL2 panel (gate AJ). When assessing the engulfment, the macrophages which engulfed apoptotic targets can be seen as a population of larger and more complex events in panel FSC/SSC (black) which were then evaluated (and measured as % cells which engulfed fluorescent targets) in panel FSC/FL2. The quenching with trypan blue discriminated engulfed from potentially attached apoptotic targets. (B–D) Efferocytosis of apoptotic Jurkat cells by rat alveolar macrophages (NR8383 cell line) in the presence of alginate at the indicated concentrations (B, 24h) and time points (C, 2.5mg/ml). Efferocytosis was expressed as relative phagocytic index (% of vehicle control; mean+SEM; n=3; (mean+SEM of control, 47.35+2.49); B: ANOVA, p≤.0001; Tukey's post-hoc, *p≤0.0001 and #p≤0.01); (C) (mean+SEM of control, 35.55+2.55); ANOVA, p≤.0001; Tukey's post-hoc, *p≤0.0001. (D) Efferocytosis index of rat alveolar macrophages (NR8383) following exposure to alginate (2.5mg/ml; 4h). Engulfment was assessed in co-cultures in the presence of alginate (present), immediately following removal of alginate (rinsed), or 24h following removal of alginate (rinsed & recovered). (Mean+SEM of control, 29.9+3.24); n=3; ANOVA, p≤.0001; Tukey's post-hoc, #p≤<0.0001, $p<0.01, and *p<0.05. (E–F) Metabolic activity measured by MTT assay in macrophages in the following conditions: untreated, vehicle treated (water) and alginate (2.5mg/ml) treated for 4h and 24h, respectively (mean+SEM, n=3). Journal of Cystic Fibrosis 2015 14, 70-77DOI: (10.1016/j.jcf.2014.06.009) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Impact of lipopolysaccharide (LPS) in alginate on efferocytosis. Efferocytosis index of alveolar macrophages (NR8383) following exposure to alginate (2.5mg/ml; 4h; 0.25EULPS/ml of media) compared to alginate preparations with low LPS contamination (final concentrations of LPS in media as indicated), or to LPS alone (1EU/ml). Mean+SEM; (mean+SEM of control, 53.17+7.31); n=3; ANOVA, p<0.0001; Tukey's post-hoc, *p<0.0001, #p<0.005, and $p<0.01. Journal of Cystic Fibrosis 2015 14, 70-77DOI: (10.1016/j.jcf.2014.06.009) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Efferocytosis of alveolar macrophages exposed to P. aeruginosa strains. Efferocytosis index of rat alveolar macrophages (NR8383) during exposure to the following strains of P. aeruginosa: wild type (WT; non-mucoid; PA14), mutated (virulence-attenuated PAKO), or mucoid (alginate overproducer; FRD1). The ratio of bacteria: macrophages: apoptotic cells during co-culture was 1:5:5. Mean+SEM; (mean+SEM of control, 50.13+4.8); n=3; ANOVA, p<0.0001; Tukey's post-hoc, *p<0.0001; #p<0.01. Journal of Cystic Fibrosis 2015 14, 70-77DOI: (10.1016/j.jcf.2014.06.009) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Fig. 4 Effect of alginate lyase (AL) on efferocytosis inhibition by alginate and alginate-producing P. aeruginosa. (A) AL activity (mU/min; pH7.4) measured during incubation of purified AL (1U/ml) with its substrate alginate (Alg, 2.5mg/ml), compared to controls such as vehicle (Veh), alginate alone, or AL in the absence of substrate. Mean+SEM; n=3. (B) Effect of pre-incubation of AL with alginate (at the indicated concentrations; 1:30 v:v ratio AL:alginate; 45min.) on efferocytosis of alveolar macrophages (NR8383 cells) exposed to alginate (2.5mg/ml; 4h). Mean+SEM; (mean+SEM of control, 40.62+4.3); n=6; t-test, *p<0.05. (C) Effect of pre-incubation of AL (1U/ml; 4h) with mucoid P. aeruginosa (alginate overproducer; FRD1) on efferocytosis of human peripheral blood monocyte (THP-1)-derived macrophages. The ratio of bacteria: macrophages:apoptotic cells was 2.5:1:5. Mean+SEM; (mean+SEM of control, 48.19+5.03); n=3; ANOVA, p<0.0001; Tukey's post-hoc, *p<0.01, #p<0.05. Journal of Cystic Fibrosis 2015 14, 70-77DOI: (10.1016/j.jcf.2014.06.009) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions